These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8227338)

  • 1. Opioid antagonist diprenorphine microinjected into parabrachial nucleus selectively inhibits vasopressin response to hypovolemic stimuli in the rat.
    Iwasaki Y; Gaskill MB; Fu R; Saper CB; Robertson GL
    J Clin Invest; 1993 Nov; 92(5):2230-9. PubMed ID: 8227338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the nonselective opioid antagonist diprenorphine on vasopressin secretion in the rat.
    Iwasaki Y; Gaskill MB; Boss CA; Robertson GL
    Endocrinology; 1994 Jan; 134(1):48-54. PubMed ID: 8275962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of selective opioid antagonists on vasopressin secretion in the rat.
    Iwasaki Y; Gaskill MB; Robertson GL
    Endocrinology; 1994 Jan; 134(1):55-62. PubMed ID: 8275969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats.
    Carter DA; Lightman SL
    J Physiol; 1985 Oct; 367():363-75. PubMed ID: 2997441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diprenorphine inhibits selectively the vasopressin response to hypovolemic stimuli.
    Robertson GL; Oiso Y; Vokes TP; Gaskill MB
    Trans Assoc Am Physicians; 1985; 98():322-33. PubMed ID: 3842202
    [No Abstract]   [Full Text] [Related]  

  • 6. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
    Welch SP
    J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of Leu-enkephalin in the nucleus tractus solitarius of the rat.
    Feldman PD; Parveen N; Sezen S
    Brain Res; 1996 Feb; 709(2):331-36. PubMed ID: 8833772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of opioids on CSF vasopressin concentration in newborn pigs.
    Armstead WM; Crofton JT; Share L; Mirro R; Zuckerman SL; Leffler CW
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H862-7. PubMed ID: 1348399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of exocrine pancreatic secretion by opiates is mediated by suppression of cholinergic transmission: characterization of receptor subtypes.
    Louie DS; Chen HT; Owyang C
    J Pharmacol Exp Ther; 1988 Jul; 246(1):132-6. PubMed ID: 2455787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid regulation of mucosal ion transport in the mouse isolated jejunum.
    Sheldon RJ; Rivière PJ; Malarchik ME; Moseberg HI; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1990 Apr; 253(1):144-51. PubMed ID: 2329501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
    Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis.
    Oiso Y; Iwasaki Y; Kondo K; Takatsuki K; Tomita A
    Neuroendocrinology; 1988 Dec; 48(6):658-62. PubMed ID: 3251164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.